Work

Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials

Year: 2010

Type: article

Source: Cardiovascular Therapeutics

DOI: 10.1111/j.1755-5922.2010.00146.x

Authors: Henry Krum, John J.V. McMurray, Edward Horton, Teresa Gerlock, Bjoern Holzhauer, Lineke Zuurman, Steven M. Haffner, M. Angelyn Bethel, Rury R. Holman, Robert M. Califf

Institutions: The Alfred Hospital, Monash Health, Monash University, University of Glasgow, Brigham and Women's Hospital, Harvard University, Novartis (Switzerland), The University of Texas at San Antonio Health Science Center, University of Oxford, Duke Medical Center, Oxford Centre for Diabetes, Endocrinology and Metabolism, Duke Clinical Research Institute

Language: English

Topic: Diabetes, Cardiovascular Risks, and Lipoproteins

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1995834288

FWCI: 1.206

Cites: 19

Cited by: 10

Related to: 10